Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Food . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
High purity NAG synthesis via chitin hydrolysis. Cost-effective, scalable process for pharma and nutrition supply chains.
Patent CN108948105A details a novel five-step chemical synthesis for high-purity GAMG. This process offers significant supply chain stability and cost reduction advantages.
Patent CN106045843A details a mild synthesis route for calcium 3-methyl-2-oxovalerate, offering high purity and scalable manufacturing for pharmaceutical intermediates.
Patent CN113564151A reveals high-activity CsCE mutants enabling green lactulose synthesis with superior thermal stability and conversion rates.
Patent CN113025544A reveals efficient whole-cell catalysis for L-phenyllactic acid. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN108546698A reveals high-activity aspartase mutant for L-aspartic acid. Enables cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN103408620B details high yield neohesperidin synthesis. Reduces cost and pollution significantly. Suitable for global food and pharma supply chains demanding quality.
Patent CN111747910B details a novel gamma-decalactone preparation using 3-hydroxydecanoic acid, offering reduced waste and superior fragrance profiles for flavor manufacturers.
Patent CN104098617A details a high-yield sucrose-6-acetate method. This report analyzes cost reduction and supply chain reliability for sucralose manufacturing.
Novel room temperature process reduces costs and improves purity for pharmaceutical intermediates supply chain reliability and commercial scale-up efficiency.
Patent CN1169418A details a novel Lewis acid-catalyzed condensation for polyene esters, offering superior gamma-selectivity and cost reduction in carotenoid manufacturing compared to Wittig reactions.
Advanced chemical resolution process for L-Valine and D-Valine using DBTA. Delivers >98% optical purity and scalable manufacturing for pharmaceutical intermediates.
Novel biocatalytic route for Hydroxytyrosol using polyphenol oxidase and ascorbic acid inhibition ensures high purity and scalable production for pharmaceutical intermediates.
Patent CN111763703B reveals a novel DMF-based enzymatic route for sucrose-6-ethyl ester, offering higher yields and greener processing for reliable sweetener intermediate supply chains.
Patent CN101899484B details a novel co-immobilization method for genipin production, offering high purity, extended enzyme stability, and significant cost reductions for supply chains.
Novel dihydroorotase method for alpha-aspartyl peptides. Reduces racemization, simplifies purification. Ideal for sweetener and pharma intermediate manufacturing.
Patent CN1298860C reveals enzymatic conversion for high-purity GABA. Achieve cost reduction in pharmaceutical intermediates manufacturing with scalable biocatalysis.
Patent CN1062604C details enzymatic DL-Methionine resolution. Achieves high yield and purity. Offers cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Novel liquid-liquid two-phase method reduces DMF decomposition and boosts yield for sucralose-6-acetate. Cost-effective and scalable manufacturing solution for global supply chains.
Patent CN113248442B reveals a cost-effective acetone-based route for ergothioneine intermediates, offering significant supply chain advantages for pharmaceutical manufacturers.